Chief Physician, Professor, and Doctoral Supervisor in the Department of Cardiology at Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine. Chief Physician, Professor, and Doctoral Supervisor in the Department of Cardiology at Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine. Specializes in the diagnosis and treatment of various types of pulmonary vascular diseases; interventional diagnosis and treatment of coronary heart disease. Graduated from the Department of Medicine at Shanghai Second Medical University in 1990 and obtained a Master of Medicine degree in 1995. In 2006, went to the Cardiac Catheterization Laboratory of Berlin Emergency Center in Germany for training in cardiac catheterization techniques, and was promoted to Chief Physician in the Department of Cardiology at Renji Hospital in 2007. In 2015, obtained a doctoral degree from Shanghai Jiao Tong University, and in 2019, obtained the qualification of Doctoral Supervisor. Has long been engaged in clinical, scientific research, and teaching work in pulmonary vascular diseases. Has published a total of 101 research papers; in 1999, published the first SCI paper on pulmonary arterial hypertension in China; the results of multiple studies have been incorporated into multiple cardiovascular clinical guidelines and medical standards, including the "European Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension," "Chinese Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension," and "Chinese Guidelines for the Diagnosis and Treatment of Pulmonary Embolism." Chief editor of one monograph, "Oriental Heart Library - Case Analysis of Pulmonary Vascular Diseases," and participated in the compilation of eight large-scale academic monographs; participated in the compilation of six guidelines and expert consensus on pulmonary vascular diseases, including the "Chinese Expert Consensus on the Diagnosis and Treatment of Pulmonary Vein Stenosis" and the "Chinese Expert Consensus on Exercise Rehabilitation for Adults with Pulmonary Hypertension." Presided over 10 scientific research projects, including general projects of the National Natural Science Foundation of China, and participated in National Key Technology R&D Program projects during the 11th Five-Year Plan, 12th Five-Year Plan, and 13th Five-Year Plan; led one domestic multicenter clinical study and participated as a principal investigator in four international multicenter clinical studies; in September 2023, participated in the PADN-HF-PH study and completed the first percutaneous pulmonary artery denervation procedure in Shanghai. Major achievements won the second prize of the 2021 Shanghai Medical Science and Technology Award; presided over the organization of ten sessions of the "Pujiang Voice" Pulmonary Vascular Disease Forum and two sessions of the "Pujiang Voice" Vascular Critical Care Seminar. Was selected for the "Hurun Ping An China Good Doctor List" for two consecutive years in 2017 and 2018; in 2019, received the title of "Pujiang Famous Doctor" at Renji Hospital South Campus, and has received widespread recognition and praise from patients.